Literature DB >> 1701344

Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein.

T Matsuguchi1, S Okamura, C Kawasaki, Y Niho.   

Abstract

The production of interleukin (IL) 6 from six human liver cell lines, including Chang liver, HLF, HLE, HepG2, PLC/PRF/5, and HuH-7, was investigated using enzyme-linked immunosorbent assay and Northern blot analysis. When cells were cultured in the presence of 12-O-tetradecanoylphorbol-13-acetate, significant amounts of IL6 were detected in the culture supernatants of Chang liver cells, HLF cells, and HLE cells. However, IL6 was not detected in the culture supernatants from HepG2 cells, PLC/PRF/5 cells, or HuH-7 cells which had been treated similarly. To further investigate the production of IL6, expression of the IL6 gene was studied. Results of Northern blot analysis using IL6 complementary DNA as a probe showed that the induction was initiated at the mRNA level. Moreover, IL6 mRNA was also induced by IL1 beta and tumor necrosis factor but not by a calcium ionophore (A23187) or IL6 itself in Chang liver cells. This is the first study to demonstrate the production of human IL6 in liver cells. Furthermore, when the production of alpha-fetoprotein (AFP) from the liver cell lines was examined, the three that were able to produce IL6 failed to produce AFP, whereas the other three cell lines succeeded in producing AFP. These observations may indicate the heterogeneous origin of the liver cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701344

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Serum interleukin-6 and -10 levels in patients with gastric cancer.

Authors:  Masahide Ikeguchi; Tomoko Hatada; Manabu Yamamoto; Takanori Miyake; Tomonori Matsunaga; Youji Fukumoto; Yoshinori Yamada; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

2.  Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Fabio D'Antona; Ada-Maria Florena; Emanuele La Spada; Angela Terranova; Melchiorre Cervello; Natale D'Alessandro; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma.

Authors:  G Y Chau; C W Wu; W Y Lui; T J Chang; H L Kao; L H Wu; K L King; C C Loong; C Y Hsia; C W Chi
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  Cytotoxicity of three South African medicinal plants using the Chang liver cell line.

Authors:  Wilfred Mbeng Otang; Donald Scott Grierson; Roland Ndip Ndip
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-01-28

5.  Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.

Authors:  Abdel-Rahman N Zekri; Mohammed S El-Din Ashour; Ahmed Hassan; Hanaa M Alam El-Din; Amal M R El-Shehaby; Maha A Abu-Shady
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

6.  Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.

Authors:  J S Goydos; A M Brumfield; E Frezza; A Booth; M T Lotze; S E Carty
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

7.  Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

Authors:  Y Kita; Y Iwaki; A J Demetris; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

8.  Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.

Authors:  Norberto C Chavez-Tapia; Natalia Rosso; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2012-03-01       Impact factor: 3.067

9.  Autonomous expressions of cytokine genes by human lung cancer cells and their paracrine regulation.

Authors:  K Mizuno; S Sone; E Orino; A Nii; T Ogura
Journal:  Jpn J Cancer Res       Date:  1994-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.